TrialHepatology international2022
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial.
Wei-Ting Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it